https://www.findatrial.com/ 2026-11-15 daily 1.0 https://www.findatrial.com/about 2026-11-15 monthly 0.8 https://www.findatrial.com/how-it-works 2026-11-15 monthly 0.8 https://www.findatrial.com/clinical-trials-guide 2026-11-15 monthly 0.8 https://www.findatrial.com/faq 2026-11-15 monthly 0.8 https://www.findatrial.com/our-mission 2026-11-15 monthly 0.5 https://www.findatrial.com/patient-resources 2026-11-15 monthly 0.5 https://www.findatrial.com/contact 2026-11-15 monthly 0.5 https://www.findatrial.com/blog 2026-11-15 monthly 0.5 https://www.findatrial.com/privacy-policy 2026-11-15 yearly 0.3 https://www.findatrial.com/terms-of-service 2026-11-15 yearly 0.3 https://www.findatrial.com/disclaimer 2026-11-15 yearly 0.3 https://www.findatrial.com/outlook 2026-11-14 weekly 0.8 https://www.findatrial.com/outlook/acute-lymphoblastic-leukemia 2026-11-14 weekly 0.9 https://www.findatrial.com/outlook/acute-myeloid-leukemia 2026-11-13 weekly 0.9 https://www.findatrial.com/outlook/adrenocortical-carcinoma 2026-11-12 weekly 0.9 https://www.findatrial.com/outlook/al-amyloidosis 2026-11-14 weekly 0.9 https://www.findatrial.com/outlook/alopecia-areata 2026-11-13 weekly 0.9 https://www.findatrial.com/outlook/als 2026-11-13 weekly 0.9 https://www.findatrial.com/outlook/alzheimers-disease 2026-11-12 weekly 0.9 https://www.findatrial.com/outlook/anal-cancer 2026-11-12 weekly 0.9 https://www.findatrial.com/outlook/anaplastic-thyroid-cancer 2026-11-12 weekly 0.9 https://www.findatrial.com/outlook/attr-cardiomyopathy 2026-11-14 weekly 0.9 https://www.findatrial.com/outlook/bladder-cancer 2026-11-13 weekly 0.9 https://www.findatrial.com/outlook/cervical-cancer 2026-11-13 weekly 0.9 https://www.findatrial.com/outlook/cholangiocarcinoma 2026-11-13 weekly 0.9 https://www.findatrial.com/outlook/chordoma 2026-11-13 weekly 0.9 https://www.findatrial.com/outlook/chronic-cough 2026-11-12 weekly 0.9 https://www.findatrial.com/outlook/chronic-low-back-pain 2026-11-12 weekly 0.9 https://www.findatrial.com/outlook/chronic-lymphocytic-leukemia 2026-11-13 weekly 0.9 https://www.findatrial.com/outlook/chronic-myeloid-leukemia 2026-11-14 weekly 0.9 https://www.findatrial.com/outlook/chronic-prostatitis 2026-11-13 weekly 0.9 https://www.findatrial.com/outlook/cidp 2026-11-14 weekly 0.9 https://www.findatrial.com/outlook/cluster-headache 2026-11-13 weekly 0.9 https://www.findatrial.com/outlook/crohns-disease 2026-11-12 weekly 0.9 https://www.findatrial.com/outlook/diffuse-large-b-cell-lymphoma 2026-11-13 weekly 0.9 https://www.findatrial.com/outlook/endometrial-cancer 2026-11-13 weekly 0.9 https://www.findatrial.com/outlook/eosinophilic-esophagitis 2026-11-13 weekly 0.9 https://www.findatrial.com/outlook/esophageal-squamous-cell-carcinoma 2026-11-12 weekly 0.9 https://www.findatrial.com/outlook/essential-tremor 2026-11-13 weekly 0.9 https://www.findatrial.com/outlook/fibromyalgia 2026-11-12 weekly 0.9 https://www.findatrial.com/outlook/follicular-lymphoma 2026-11-14 weekly 0.9 https://www.findatrial.com/outlook/gastrointestinal-stromal-tumor 2026-11-13 weekly 0.9 https://www.findatrial.com/outlook/generalized-anxiety-disorder 2026-11-12 weekly 0.9 https://www.findatrial.com/outlook/glioblastoma 2026-11-13 weekly 0.9 https://www.findatrial.com/outlook/hidradenitis-suppurativa 2026-11-13 weekly 0.9 https://www.findatrial.com/outlook/hodgkin-lymphoma 2026-11-12 weekly 0.9 https://www.findatrial.com/outlook/hypertrophic-cardiomyopathy 2026-11-14 weekly 0.9 https://www.findatrial.com/outlook/idiopathic-pulmonary-fibrosis 2026-11-13 weekly 0.9 https://www.findatrial.com/outlook/iga-nephropathy 2026-11-14 weekly 0.9 https://www.findatrial.com/outlook/interstitial-cystitis 2026-11-13 weekly 0.9 https://www.findatrial.com/outlook/kidney-cancer 2026-11-13 weekly 0.9 https://www.findatrial.com/outlook/kidney-stones 2026-11-13 weekly 0.9 https://www.findatrial.com/outlook/laryngeal-cancer 2026-11-14 weekly 0.9 https://www.findatrial.com/outlook/lichen-sclerosus 2026-11-13 weekly 0.9 https://www.findatrial.com/outlook/liver-cancer 2026-11-13 weekly 0.9 https://www.findatrial.com/outlook/low-grade-glioma 2026-11-14 weekly 0.9 https://www.findatrial.com/outlook/low-testosterone 2026-11-13 weekly 0.9 https://www.findatrial.com/outlook/lupus 2026-11-13 weekly 0.9 https://www.findatrial.com/outlook/major-depressive-disorder 2026-11-12 weekly 0.9 https://www.findatrial.com/outlook/mantle-cell-lymphoma 2026-11-14 weekly 0.9 https://www.findatrial.com/outlook/marginal-zone-lymphoma 2026-11-14 weekly 0.9 https://www.findatrial.com/outlook/melanoma 2026-11-13 weekly 0.9 https://www.findatrial.com/outlook/meningioma 2026-11-14 weekly 0.9 https://www.findatrial.com/outlook/merkel-cell-carcinoma 2026-11-12 weekly 0.9 https://www.findatrial.com/outlook/mesothelioma 2026-11-13 weekly 0.9 https://www.findatrial.com/outlook/multiple-myeloma 2026-11-13 weekly 0.9 https://www.findatrial.com/outlook/multiple-sclerosis 2026-11-12 weekly 0.9 https://www.findatrial.com/outlook/myasthenia-gravis 2026-11-13 weekly 0.9 https://www.findatrial.com/outlook/myelodysplastic-syndromes 2026-11-14 weekly 0.9 https://www.findatrial.com/outlook/myelofibrosis 2026-11-14 weekly 0.9 https://www.findatrial.com/outlook/narcolepsy 2026-11-13 weekly 0.9 https://www.findatrial.com/outlook/nasopharyngeal-carcinoma 2026-11-14 weekly 0.9 https://www.findatrial.com/outlook/neuroendocrine-tumors 2026-11-13 weekly 0.9 https://www.findatrial.com/outlook/nocturia 2026-11-12 weekly 0.9 https://www.findatrial.com/outlook/non-obstructive-azoospermia 2026-11-12 weekly 0.9 https://www.findatrial.com/outlook/obstructive-sleep-apnea 2026-11-12 weekly 0.9 https://www.findatrial.com/outlook/oral-cavity-cancer 2026-11-13 weekly 0.9 https://www.findatrial.com/outlook/osteosarcoma 2026-11-13 weekly 0.9 https://www.findatrial.com/outlook/ovarian-cancer 2026-11-13 weekly 0.9 https://www.findatrial.com/outlook/pancreatic-cancer 2026-11-13 weekly 0.9 https://www.findatrial.com/outlook/parkinsons-disease 2026-11-12 weekly 0.9 https://www.findatrial.com/outlook/penile-cancer 2026-11-12 weekly 0.9 https://www.findatrial.com/outlook/peripheral-t-cell-lymphoma 2026-11-14 weekly 0.9 https://www.findatrial.com/outlook/peyronies-disease 2026-11-12 weekly 0.9 https://www.findatrial.com/outlook/polycythemia-vera 2026-11-14 weekly 0.9 https://www.findatrial.com/outlook/primary-biliary-cholangitis 2026-11-14 weekly 0.9 https://www.findatrial.com/outlook/ptsd 2026-11-12 weekly 0.9 https://www.findatrial.com/outlook/pulmonary-arterial-hypertension 2026-11-14 weekly 0.9 https://www.findatrial.com/outlook/rosacea 2026-11-12 weekly 0.9 https://www.findatrial.com/outlook/sickle-cell-disease 2026-11-13 weekly 0.9 https://www.findatrial.com/outlook/sjogrens-disease 2026-11-13 weekly 0.9 https://www.findatrial.com/outlook/small-cell-lung-cancer 2026-11-13 weekly 0.9 https://www.findatrial.com/outlook/smoldering-myeloma 2026-11-14 weekly 0.9 https://www.findatrial.com/outlook/soft-tissue-sarcoma 2026-11-14 weekly 0.9 https://www.findatrial.com/outlook/stomach-cancer 2026-11-13 weekly 0.9 https://www.findatrial.com/outlook/systemic-sclerosis 2026-11-14 weekly 0.9 https://www.findatrial.com/outlook/testicular-cancer 2026-11-12 weekly 0.9 https://www.findatrial.com/outlook/thymoma-and-thymic-carcinoma 2026-11-12 weekly 0.9 https://www.findatrial.com/outlook/thyroid-cancer 2026-11-12 weekly 0.9 https://www.findatrial.com/outlook/thyroid-eye-disease 2026-11-14 weekly 0.9 https://www.findatrial.com/outlook/trigeminal-neuralgia 2026-11-12 weekly 0.9 https://www.findatrial.com/outlook/ulcerative-colitis 2026-11-13 weekly 0.9 https://www.findatrial.com/outlook/urethral-stricture 2026-11-12 weekly 0.9 https://www.findatrial.com/outlook/uveal-melanoma 2026-11-13 weekly 0.9 https://www.findatrial.com/study/aall1731-blinatumomab-children-standard-risk 2026-11-14 monthly 0.6 https://www.findatrial.com/study/ablative-laser-lichen-sclerosus-review 2026-11-13 monthly 0.6 https://www.findatrial.com/study/abtect-obefazimod-maintenance 2026-11-13 monthly 0.6 https://www.findatrial.com/study/acacia-hcm-aficamten-nonobstructive 2026-11-14 monthly 0.6 https://www.findatrial.com/study/acc-adjuvant-mitotane-rt-review 2026-11-12 monthly 0.6 https://www.findatrial.com/study/action-1-ryz101-actinium 2026-11-13 monthly 0.6 https://www.findatrial.com/study/adhere-efgartigimod-cidp 2026-11-14 monthly 0.6 https://www.findatrial.com/study/adjuvant-chemotherapy-sarcoma-meta-analysis 2026-11-14 monthly 0.6 https://www.findatrial.com/study/adriatic-durvalumab-limited-stage-sclc 2026-11-13 monthly 0.6 https://www.findatrial.com/study/advance-outcomes-ralinepag 2026-11-14 monthly 0.6 https://www.findatrial.com/study/aga-aasld-pbc-guideline-2026 2026-11-14 monthly 0.6 https://www.findatrial.com/study/ai-discovered-tnik-inhibitor 2026-11-13 monthly 0.6 https://www.findatrial.com/study/align-atrasentan-iga-nephropathy 2026-11-14 monthly 0.6 https://www.findatrial.com/study/all-oral-decitabine-cedazuridine-venetoclax 2026-11-13 monthly 0.6 https://www.findatrial.com/study/allegory-obinutuzumab-sle 2026-11-13 monthly 0.6 https://www.findatrial.com/study/alliance-a071401-abemaciclib-meningioma 2026-11-14 monthly 0.6 https://www.findatrial.com/study/alzheimers-blood-tests 2026-11-12 monthly 0.6 https://www.findatrial.com/study/amplify-7p-camupepimut-vaccine 2026-11-13 monthly 0.6 https://www.findatrial.com/study/amplify-acalabrutinib-venetoclax-fixed 2026-11-13 monthly 0.6 https://www.findatrial.com/study/anal-self-swab-review 2026-11-12 monthly 0.6 https://www.findatrial.com/study/andromeda-final-daratumumab-al-amyloidosis 2026-11-14 monthly 0.6 https://www.findatrial.com/study/applause-iptacopan-final-24-month 2026-11-14 monthly 0.6 https://www.findatrial.com/study/aquila-daratumumab-high-risk-smoldering 2026-11-14 monthly 0.6 https://www.findatrial.com/study/artemis-011-risvutatug-rezetecan 2026-11-13 monthly 0.6 https://www.findatrial.com/study/asc4first-asciminib-first-line-96-weeks 2026-11-14 monthly 0.6 https://www.findatrial.com/study/ascembl-asciminib-vs-bosutinib-4-years 2026-11-14 monthly 0.6 https://www.findatrial.com/study/atc-adjuvant-pembrolizumab 2026-11-12 monthly 0.6 https://www.findatrial.com/study/atc-atezolizumab-cohorts 2026-11-12 monthly 0.6 https://www.findatrial.com/study/atc-braf-mek-review 2026-11-12 monthly 0.6 https://www.findatrial.com/study/atc-lenvatinib-pembrolizumab 2026-11-12 monthly 0.6 https://www.findatrial.com/study/atezolizumab-thymic-carcinoma 2026-11-12 monthly 0.6 https://www.findatrial.com/study/atomic-meso-pegargiminase 2026-11-13 monthly 0.6 https://www.findatrial.com/study/attribute-cm-acoramidis-outcomes 2026-11-14 monthly 0.6 https://www.findatrial.com/study/augment-101-revumenib-npm1 2026-11-13 monthly 0.6 https://www.findatrial.com/study/autogene-cevumeran-long-lived-t-cells 2026-11-13 monthly 0.6 https://www.findatrial.com/study/balloon-dilation-review 2026-11-12 monthly 0.6 https://www.findatrial.com/study/be-heard-bimekizumab-hs 2026-11-13 monthly 0.6 https://www.findatrial.com/study/benralizumab-eoe-messina 2026-11-13 monthly 0.6 https://www.findatrial.com/study/biib078-c9orf72-als 2026-11-13 monthly 0.6 https://www.findatrial.com/study/bilateral-gamma-knife-essential-tremor 2026-11-13 monthly 0.6 https://www.findatrial.com/study/bivalent-car-t-recurrent-glioblastoma 2026-11-13 monthly 0.6 https://www.findatrial.com/study/botox-trigeminal-neuralgia-review 2026-11-12 monthly 0.6 https://www.findatrial.com/study/botox-vs-instillations-ic 2026-11-13 monthly 0.6 https://www.findatrial.com/study/brachyury-vaccine-radiation-chordoma 2026-11-13 monthly 0.6 https://www.findatrial.com/study/brave-aa1-baricitinib-withdrawal 2026-11-13 monthly 0.6 https://www.findatrial.com/study/break-wave-burst-wave-lithotripsy-pivotal 2026-11-13 monthly 0.6 https://www.findatrial.com/study/brexpiprazole-ptsd 2026-11-12 monthly 0.6 https://www.findatrial.com/study/bruin-cll-313-pirtobrutinib-first-line 2026-11-13 monthly 0.6 https://www.findatrial.com/study/bruin-pirtobrutinib-marginal-zone 2026-11-14 monthly 0.6 https://www.findatrial.com/study/cabinet-cabozantinib-net 2026-11-13 monthly 0.6 https://www.findatrial.com/study/cabozantinib-acc-phase2 2026-11-12 monthly 0.6 https://www.findatrial.com/study/cadonilimab-first-treatment 2026-11-12 monthly 0.6 https://www.findatrial.com/study/cadonilimab-with-chemoradiation 2026-11-12 monthly 0.6 https://www.findatrial.com/study/camrelizumab-apatinib-acc 2026-11-12 monthly 0.6 https://www.findatrial.com/study/car-t-early-ms 2026-11-12 monthly 0.6 https://www.findatrial.com/study/cardio-ttransform-eplontersen 2026-11-14 monthly 0.6 https://www.findatrial.com/study/cares-anselamimab-al-amyloidosis 2026-11-14 monthly 0.6 https://www.findatrial.com/study/castle-cd19-car-t-autoimmune 2026-11-13 monthly 0.6 https://www.findatrial.com/study/cdk4-6-inhibition-chordoma 2026-11-13 monthly 0.6 https://www.findatrial.com/study/celestimo-mosunetuzumab-lenalidomide 2026-11-14 monthly 0.6 https://www.findatrial.com/study/cendakimab-eoe-phase-3 2026-11-13 monthly 0.6 https://www.findatrial.com/study/checkmate-067-10-year 2026-11-13 monthly 0.6 https://www.findatrial.com/study/checkmate-358-nivolumab-merkel 2026-11-12 monthly 0.6 https://www.findatrial.com/study/checkmate-743-5-year 2026-11-13 monthly 0.6 https://www.findatrial.com/study/checkmate-9dw-nivolumab-ipilimumab 2026-11-13 monthly 0.6 https://www.findatrial.com/study/clarity-ad 2026-11-12 monthly 0.6 https://www.findatrial.com/study/cll17-fixed-duration-vs-continuous 2026-11-13 monthly 0.6 https://www.findatrial.com/study/cluster-headache-diagnostic-delay 2026-11-13 monthly 0.6 https://www.findatrial.com/study/co2-laser-vs-clobetasol-lichen-sclerosus 2026-11-13 monthly 0.6 https://www.findatrial.com/study/commands-luspatercept-vs-epoetin 2026-11-14 monthly 0.6 https://www.findatrial.com/study/comp360-depression 2026-11-12 monthly 0.6 https://www.findatrial.com/study/coral-nalbuphine-ipf-cough 2026-11-12 monthly 0.6 https://www.findatrial.com/study/cosmic-311-cabozantinib 2026-11-12 monthly 0.6 https://www.findatrial.com/study/cp-cpps-sexual-dysfunction-review 2026-11-13 monthly 0.6 https://www.findatrial.com/study/crossing-tezepelumab-eoe 2026-11-13 monthly 0.6 https://www.findatrial.com/study/ctdna-mrd-pancreatic-meta-analysis 2026-11-13 monthly 0.6 https://www.findatrial.com/study/ctdna-risk-adaptive-nasopharyngeal 2026-11-14 monthly 0.6 https://www.findatrial.com/study/dahlias-nipocalimab-sjogrens 2026-11-13 monthly 0.6 https://www.findatrial.com/study/daratumumab-high-risk-smoldering-myeloma 2026-11-13 monthly 0.6 https://www.findatrial.com/study/daridorexant-insomnia-nocturia 2026-11-12 monthly 0.6 https://www.findatrial.com/study/dart-ipi-nivo-acc 2026-11-12 monthly 0.6 https://www.findatrial.com/study/dellphi-304-tarlatamab-second-line 2026-11-13 monthly 0.6 https://www.findatrial.com/study/dellphi-305-tarlatamab-durvalumab 2026-11-13 monthly 0.6 https://www.findatrial.com/study/descartes-08-mrna-car-t-myasthenia 2026-11-13 monthly 0.6 https://www.findatrial.com/study/destiny-gastric04-trastuzumab-deruxtecan 2026-11-13 monthly 0.6 https://www.findatrial.com/study/deuruxolitinib-thrive-aa 2026-11-13 monthly 0.6 https://www.findatrial.com/study/diamond-toripalimab-without-cisplatin 2026-11-14 monthly 0.6 https://www.findatrial.com/study/dipper-adjuvant-camrelizumab-nasopharyngeal 2026-11-14 monthly 0.6 https://www.findatrial.com/study/dorsal-ventral-graft-review 2026-11-12 monthly 0.6 https://www.findatrial.com/study/dt120-anxiety 2026-11-12 monthly 0.6 https://www.findatrial.com/study/dt120-depression 2026-11-12 monthly 0.6 https://www.findatrial.com/study/duloxetine-vs-amitriptyline-cpps 2026-11-13 monthly 0.6 https://www.findatrial.com/study/dupilumab-eoe-children-1-11 2026-11-13 monthly 0.6 https://www.findatrial.com/study/e1910-blinatumomab-adults-mrd-negative 2026-11-14 monthly 0.6 https://www.findatrial.com/study/echo-acalabrutinib-bendamustine-rituximab 2026-11-14 monthly 0.6 https://www.findatrial.com/study/efgartigimod-thymoma-myasthenia 2026-11-12 monthly 0.6 https://www.findatrial.com/study/elative-elafibranor-pbc 2026-11-14 monthly 0.6 https://www.findatrial.com/study/elritercept-lower-risk-mds-phase-2 2026-11-14 monthly 0.6 https://www.findatrial.com/study/emerald-1-tace-durvalumab-bevacizumab 2026-11-13 monthly 0.6 https://www.findatrial.com/study/empagliflozin-kidney-stones-phase-2 2026-11-13 monthly 0.6 https://www.findatrial.com/study/engineered-microbe-oxalate 2026-11-13 monthly 0.6 https://www.findatrial.com/study/enrgy-zenocutuzumab-nrg1-pancreatic 2026-11-13 monthly 0.6 https://www.findatrial.com/study/enrich-ibrutinib-rituximab-older-adults 2026-11-14 monthly 0.6 https://www.findatrial.com/study/eortc-22033-temozolomide-vs-radiotherapy-mature 2026-11-14 monthly 0.6 https://www.findatrial.com/study/epcore-dlbcl-1-relapsed 2026-11-13 monthly 0.6 https://www.findatrial.com/study/epcore-dlbcl-2-first-line 2026-11-13 monthly 0.6 https://www.findatrial.com/study/epcore-fl-1-epcoritamab-r2 2026-11-14 monthly 0.6 https://www.findatrial.com/study/eptinezumab-episodic-cluster-headache 2026-11-13 monthly 0.6 https://www.findatrial.com/study/erenumab-chronic-cluster-headache 2026-11-13 monthly 0.6 https://www.findatrial.com/study/escort-neo 2026-11-12 monthly 0.6 https://www.findatrial.com/study/essential3-ulixacaltamide 2026-11-13 monthly 0.6 https://www.findatrial.com/study/ev-202 2026-11-12 monthly 0.6 https://www.findatrial.com/study/ev-302-enfortumab-vedotin-pembrolizumab 2026-11-13 monthly 0.6 https://www.findatrial.com/study/ev303-perioperative-ev-pembrolizumab 2026-11-13 monthly 0.6 https://www.findatrial.com/study/evoke-semaglutide 2026-11-12 monthly 0.6 https://www.findatrial.com/study/exa-cel-crispr-sickle-cell 2026-11-13 monthly 0.6 https://www.findatrial.com/study/exenatide-pd3 2026-11-12 monthly 0.6 https://www.findatrial.com/study/felix-obecabtagene-autoleucel 2026-11-14 monthly 0.6 https://www.findatrial.com/study/fenhance 2026-11-12 monthly 0.6 https://www.findatrial.com/study/fentrepid 2026-11-12 monthly 0.6 https://www.findatrial.com/study/fibroneer-ipf-nerandomilast 2026-11-13 monthly 0.6 https://www.findatrial.com/study/firstlight-radiantlight-oveporexton 2026-11-13 monthly 0.6 https://www.findatrial.com/study/flair-mrd-guided-ibrutinib-venetoclax 2026-11-13 monthly 0.6 https://www.findatrial.com/study/freedom2-fedratinib-after-ruxolitinib 2026-11-14 monthly 0.6 https://www.findatrial.com/study/frexalimab-phase-2 2026-11-12 monthly 0.6 https://www.findatrial.com/study/fusion-ulefnersen-fus-als 2026-11-13 monthly 0.6 https://www.findatrial.com/study/fuzion-guselkumab 2026-11-12 monthly 0.6 https://www.findatrial.com/study/gimema-all2820-ponatinib-blinatumomab 2026-11-14 monthly 0.6 https://www.findatrial.com/study/glisten-linerixibat-pbc-itch 2026-11-14 monthly 0.6 https://www.findatrial.com/study/glofitamab-mantle-cell-phase-1-2 2026-11-14 monthly 0.6 https://www.findatrial.com/study/glp1-thyroid-cohort 2026-11-12 monthly 0.6 https://www.findatrial.com/study/glp1-thyroid-trials-meta 2026-11-12 monthly 0.6 https://www.findatrial.com/study/golp-neoadjuvant-intrahepatic-cholangiocarcinoma 2026-11-13 monthly 0.6 https://www.findatrial.com/study/gon-injection-episodic-cluster 2026-11-13 monthly 0.6 https://www.findatrial.com/study/h-pylori-eradication-gastric-cancer-prevention 2026-11-13 monthly 0.6 https://www.findatrial.com/study/haploidentical-bmt-sickle-cell 2026-11-13 monthly 0.6 https://www.findatrial.com/study/harmoni-2 2026-11-12 monthly 0.6 https://www.findatrial.com/study/hd16-radiation 2026-11-12 monthly 0.6 https://www.findatrial.com/study/hd21-brecadd 2026-11-12 monthly 0.6 https://www.findatrial.com/study/helios-b-vutrisiran-attr-cm 2026-11-14 monthly 0.6 https://www.findatrial.com/study/hercules-pembrolizumab-chemo 2026-11-12 monthly 0.6 https://www.findatrial.com/study/herizon-gea-01-zanidatamab 2026-11-13 monthly 0.6 https://www.findatrial.com/study/himalaya-4-year-durvalumab-tremelimumab 2026-11-13 monthly 0.6 https://www.findatrial.com/study/hiv-transplant-cancer-risk 2026-11-12 monthly 0.6 https://www.findatrial.com/study/hormones-before-surgery 2026-11-12 monthly 0.6 https://www.findatrial.com/study/hpv-vaccination-cochrane-2025 2026-11-13 monthly 0.6 https://www.findatrial.com/study/hs-20093-vs-chemotherapy 2026-11-12 monthly 0.6 https://www.findatrial.com/study/hs-biologics-network-meta-analysis 2026-11-13 monthly 0.6 https://www.findatrial.com/study/hs-genome-wide-association 2026-11-13 monthly 0.6 https://www.findatrial.com/study/hyperion-sotatercept-early-pah 2026-11-14 monthly 0.6 https://www.findatrial.com/study/i-dxd-early 2026-11-12 monthly 0.6 https://www.findatrial.com/study/ibrutinib-venetoclax-marginal-zone 2026-11-14 monthly 0.6 https://www.findatrial.com/study/iga-nephropathy-fda-decisions-2026 2026-11-14 monthly 0.6 https://www.findatrial.com/study/ignyte-rp1-nivolumab 2026-11-13 monthly 0.6 https://www.findatrial.com/study/imadgist-6-vs-3-years-imatinib 2026-11-13 monthly 0.6 https://www.findatrial.com/study/imerge-imetelstat-lower-risk-mds 2026-11-14 monthly 0.6 https://www.findatrial.com/study/imforte-lurbinectedin-atezolizumab-maintenance 2026-11-13 monthly 0.6 https://www.findatrial.com/study/immuno-prism-teclistamab-smoldering 2026-11-14 monthly 0.6 https://www.findatrial.com/study/imvigor011-ctdna-guided-atezolizumab 2026-11-13 monthly 0.6 https://www.findatrial.com/study/indigo-vorasidenib-secondary-endpoints 2026-11-14 monthly 0.6 https://www.findatrial.com/study/inmind-tafasitamab-r2 2026-11-14 monthly 0.6 https://www.findatrial.com/study/innovatv-301-tisotumab-vedotin 2026-11-13 monthly 0.6 https://www.findatrial.com/study/interlace-induction-chemotherapy 2026-11-13 monthly 0.6 https://www.findatrial.com/study/internet-cough-suppression-therapy 2026-11-12 monthly 0.6 https://www.findatrial.com/study/interpath-001-intismeran-phase-3 2026-11-13 monthly 0.6 https://www.findatrial.com/study/intrigue-ctdna-ripretinib-sunitinib 2026-11-13 monthly 0.6 https://www.findatrial.com/study/intuitt-nf2-brigatinib 2026-11-14 monthly 0.6 https://www.findatrial.com/study/ion-radioiodine 2026-11-12 monthly 0.6 https://www.findatrial.com/study/isac-proton-vs-carbon-sacral-chordoma 2026-11-13 monthly 0.6 https://www.findatrial.com/study/isotretinoin-small-studies 2026-11-12 monthly 0.6 https://www.findatrial.com/study/itm-11-edotreotide-crl 2026-11-13 monthly 0.6 https://www.findatrial.com/study/iv-fosphenytoin-trigeminal-neuralgia 2026-11-12 monthly 0.6 https://www.findatrial.com/study/iza-bren-egfr-her3-adc-nasopharyngeal 2026-11-14 monthly 0.6 https://www.findatrial.com/study/jackpot8-golidocitinib-ptcl 2026-11-14 monthly 0.6 https://www.findatrial.com/study/javelin-merkel-200-4-year 2026-11-12 monthly 0.6 https://www.findatrial.com/study/kc1036-early 2026-11-12 monthly 0.6 https://www.findatrial.com/study/keynote-017-pembrolizumab-merkel 2026-11-12 monthly 0.6 https://www.findatrial.com/study/keynote-048-5-year 2026-11-13 monthly 0.6 https://www.findatrial.com/study/keynote-412-chemoradiation 2026-11-13 monthly 0.6 https://www.findatrial.com/study/keynote-564-overall-survival 2026-11-13 monthly 0.6 https://www.findatrial.com/study/keynote-585-perioperative-pembrolizumab 2026-11-13 monthly 0.6 https://www.findatrial.com/study/keynote-689-perioperative-pembrolizumab 2026-11-14 monthly 0.6 https://www.findatrial.com/study/keynote-937-adjuvant-pembrolizumab-negative 2026-11-13 monthly 0.6 https://www.findatrial.com/study/keynote-942-intismeran-5-year 2026-11-13 monthly 0.6 https://www.findatrial.com/study/keynote-975 2026-11-12 monthly 0.6 https://www.findatrial.com/study/keynote-a18-pembrolizumab-chemoradiation 2026-11-13 monthly 0.6 https://www.findatrial.com/study/keynote-b96-pembrolizumab-paclitaxel 2026-11-13 monthly 0.6 https://www.findatrial.com/study/kunlun 2026-11-12 monthly 0.6 https://www.findatrial.com/study/lab-grown-early-sperm-cells 2026-11-12 monthly 0.6 https://www.findatrial.com/study/leap-001-lenvatinib-pembrolizumab-first-line 2026-11-13 monthly 0.6 https://www.findatrial.com/study/lecanemab-home-injection 2026-11-12 monthly 0.6 https://www.findatrial.com/study/lentiviral-gene-therapy-reduced-intensity 2026-11-13 monthly 0.6 https://www.findatrial.com/study/lenvatinib-ifosfamide-etoposide-relapsed-osteosarcoma 2026-11-13 monthly 0.6 https://www.findatrial.com/study/libra-t1-trbc1-car-t-ptcl 2026-11-14 monthly 0.6 https://www.findatrial.com/study/lichen-sclerosus-thyroid-review 2026-11-13 monthly 0.6 https://www.findatrial.com/study/liger-hn1 2026-11-12 monthly 0.6 https://www.findatrial.com/study/linvoseltamab-al-amyloidosis-phase-1-2 2026-11-14 monthly 0.6 https://www.findatrial.com/study/lirafugratinib-fda-approval-cholangiocarcinoma 2026-11-13 monthly 0.6 https://www.findatrial.com/study/litespark-005-belzutifan-everolimus 2026-11-13 monthly 0.6 https://www.findatrial.com/study/litespark-022-adjuvant-belzutifan 2026-11-13 monthly 0.6 https://www.findatrial.com/study/lms-04-doxorubicin-trabectedin-leiomyosarcoma 2026-11-14 monthly 0.6 https://www.findatrial.com/study/low-dose-isotretinoin-rosacea-review 2026-11-12 monthly 0.6 https://www.findatrial.com/study/low-sodium-oxybate-weight-effects 2026-11-13 monthly 0.6 https://www.findatrial.com/study/luma-biib122 2026-11-12 monthly 0.6 https://www.findatrial.com/study/lutetium-dotatate-equivalents-approved 2026-11-13 monthly 0.6 https://www.findatrial.com/study/majestec-3-teclistamab-daratumumab 2026-11-13 monthly 0.6 https://www.findatrial.com/study/majestec-9-teclistamab-early-relapse 2026-11-13 monthly 0.6 https://www.findatrial.com/study/mangrove-zanubrutinib-rituximab-first-line 2026-11-14 monthly 0.6 https://www.findatrial.com/study/manifest-2-pelabresib-ruxolitinib 2026-11-14 monthly 0.6 https://www.findatrial.com/study/maple-hcm-aficamten-vs-metoprolol 2026-11-14 monthly 0.6 https://www.findatrial.com/study/marizomib-newly-diagnosed-glioblastoma 2026-11-13 monthly 0.6 https://www.findatrial.com/study/matterhorn-durvalumab-flot 2026-11-13 monthly 0.6 https://www.findatrial.com/study/mdma-ptsd-status 2026-11-12 monthly 0.6 https://www.findatrial.com/study/melphalan-hepatic-delivery-focus 2026-11-13 monthly 0.6 https://www.findatrial.com/study/methylone-ptsd-status 2026-11-12 monthly 0.6 https://www.findatrial.com/study/micro-tese-live-births 2026-11-12 monthly 0.6 https://www.findatrial.com/study/mindfulness-telehealth-back-pain 2026-11-12 monthly 0.6 https://www.findatrial.com/study/mint-inebilizumab-myasthenia 2026-11-13 monthly 0.6 https://www.findatrial.com/study/mir371-rplnd-review 2026-11-12 monthly 0.6 https://www.findatrial.com/study/mobilize-riliprubart-halted 2026-11-14 monthly 0.6 https://www.findatrial.com/study/mosunetuzumab-subcutaneous-follicular 2026-11-14 monthly 0.6 https://www.findatrial.com/study/mrd2start 2026-11-12 monthly 0.6 https://www.findatrial.com/study/mrgfus-thalamotomy-essential-tremor-review 2026-11-13 monthly 0.6 https://www.findatrial.com/study/mrna-restores-sperm-in-mice 2026-11-12 monthly 0.6 https://www.findatrial.com/study/nadina-neoadjuvant-nivolumab-ipilimumab 2026-11-13 monthly 0.6 https://www.findatrial.com/study/neptunus-ianalumab-sjogrens 2026-11-13 monthly 0.6 https://www.findatrial.com/study/nex-z-magnitude-hold-lifted 2026-11-14 monthly 0.6 https://www.findatrial.com/study/nice-2 2026-11-12 monthly 0.6 https://www.findatrial.com/study/nilotinib-de-escalation-treatment-free-remission 2026-11-14 monthly 0.6 https://www.findatrial.com/study/nivopostop-adjuvant-nivolumab-head-neck 2026-11-14 monthly 0.6 https://www.findatrial.com/study/nostone-hydrochlorothiazide 2026-11-13 monthly 0.6 https://www.findatrial.com/study/nrg-gy018-pembrolizumab-overall-survival 2026-11-13 monthly 0.6 https://www.findatrial.com/study/nsaids-renal-colic-cochrane 2026-11-13 monthly 0.6 https://www.findatrial.com/study/oasiz-301-dazodalibep 2026-11-13 monthly 0.6 https://www.findatrial.com/study/ocular-rosacea-prevalence 2026-11-12 monthly 0.6 https://www.findatrial.com/study/odyssey-hcm-mavacamten-nonobstructive 2026-11-14 monthly 0.6 https://www.findatrial.com/study/olverembatinib-after-multiple-tkis 2026-11-14 monthly 0.6 https://www.findatrial.com/study/one-food-vs-four-food-elimination-eoe 2026-11-13 monthly 0.6 https://www.findatrial.com/study/optimum-02-darovasertib-crizotinib 2026-11-13 monthly 0.6 https://www.findatrial.com/study/oral-testosterone-undecanoate-trial 2026-11-13 monthly 0.6 https://www.findatrial.com/study/orarials-01-arimoclomol-als 2026-11-13 monthly 0.6 https://www.findatrial.com/study/origin-3-atacicept-iga-nephropathy 2026-11-14 monthly 0.6 https://www.findatrial.com/study/ost-her2-lung-metastatic-osteosarcoma 2026-11-13 monthly 0.6 https://www.findatrial.com/study/pacback 2026-11-12 monthly 0.6 https://www.findatrial.com/study/padova-prasinezumab 2026-11-12 monthly 0.6 https://www.findatrial.com/study/panku-esophagus01 2026-11-12 monthly 0.6 https://www.findatrial.com/study/paradigm-azacitidine-venetoclax-vs-induction 2026-11-13 monthly 0.6 https://www.findatrial.com/study/peak-bezuclastinib-sunitinib 2026-11-13 monthly 0.6 https://www.findatrial.com/study/pecati-lenvatinib-pembrolizumab 2026-11-12 monthly 0.6 https://www.findatrial.com/study/pelvic-pain-physical-therapy-review 2026-11-13 monthly 0.6 https://www.findatrial.com/study/penile-hpv-p16-review 2026-11-12 monthly 0.6 https://www.findatrial.com/study/penile-immunotherapy-review 2026-11-12 monthly 0.6 https://www.findatrial.com/study/penile-mis-lymph-node-review 2026-11-12 monthly 0.6 https://www.findatrial.com/study/peyronies-buccal-graft-surgery-review 2026-11-12 monthly 0.6 https://www.findatrial.com/study/peyronies-placebo-injections-review 2026-11-12 monthly 0.6 https://www.findatrial.com/study/phallcon-ponatinib-vs-imatinib 2026-11-14 monthly 0.6 https://www.findatrial.com/study/plato-act4-reduced-dose 2026-11-12 monthly 0.6 https://www.findatrial.com/study/pod1um-201-retifanlimab-merkel 2026-11-12 monthly 0.6 https://www.findatrial.com/study/pod1um-303-retifanlimab 2026-11-12 monthly 0.6 https://www.findatrial.com/study/polarix-5-year-followup 2026-11-13 monthly 0.6 https://www.findatrial.com/study/ponsegromab-cancer-cachexia 2026-11-13 monthly 0.6 https://www.findatrial.com/study/portec-4a-molecular-profile-adjuvant 2026-11-13 monthly 0.6 https://www.findatrial.com/study/postbiotic-vulvar-lichen-sclerosus 2026-11-13 monthly 0.6 https://www.findatrial.com/study/precision-t-orca-t-transplant 2026-11-14 monthly 0.6 https://www.findatrial.com/study/preopanc-2-folfirinox-vs-chemoradiation 2026-11-13 monthly 0.6 https://www.findatrial.com/study/prima-niraparib-final-overall-survival 2026-11-13 monthly 0.6 https://www.findatrial.com/study/primo-duvelisib-relapsed-ptcl-final 2026-11-14 monthly 0.6 https://www.findatrial.com/study/prosera-seralutinib-phase-3 2026-11-14 monthly 0.6 https://www.findatrial.com/study/prosper-fm 2026-11-12 monthly 0.6 https://www.findatrial.com/study/proton-therapy-chordoma-review 2026-11-13 monthly 0.6 https://www.findatrial.com/study/proton-vs-standard-radiation 2026-11-12 monthly 0.6 https://www.findatrial.com/study/prp-after-failed-surgery 2026-11-12 monthly 0.6 https://www.findatrial.com/study/prp-interstitial-cystitis-review 2026-11-13 monthly 0.6 https://www.findatrial.com/study/prp-peyronies-crossover 2026-11-12 monthly 0.6 https://www.findatrial.com/study/psilocybin-pulse-cluster-headache 2026-11-13 monthly 0.6 https://www.findatrial.com/study/pyruvate-kinase-activators-sickle-cell 2026-11-13 monthly 0.6 https://www.findatrial.com/study/quasar-guselkumab-induction 2026-11-13 monthly 0.6 https://www.findatrial.com/study/radiosurgery-vs-rhizotomy-trigeminal-neuralgia 2026-11-12 monthly 0.6 https://www.findatrial.com/study/ramp-201-avutometinib-defactinib-lgsoc 2026-11-13 monthly 0.6 https://www.findatrial.com/study/rano-recurrent-meningioma-benchmarks 2026-11-14 monthly 0.6 https://www.findatrial.com/study/rasolute-302-daraxonrasib 2026-11-13 monthly 0.6 https://www.findatrial.com/study/rationale-306 2026-11-12 monthly 0.6 https://www.findatrial.com/study/regency-obinutuzumab-lupus-nephritis 2026-11-13 monthly 0.6 https://www.findatrial.com/study/relevent-ramucirumab 2026-11-12 monthly 0.6 https://www.findatrial.com/study/rematch-neoadjuvant-immunochemotherapy-organ-preservation 2026-11-14 monthly 0.6 https://www.findatrial.com/study/remyelination-status 2026-11-12 monthly 0.6 https://www.findatrial.com/study/repeat-surgery-trigeminal-neuralgia-review 2026-11-12 monthly 0.6 https://www.findatrial.com/study/response-seladelpar-pbc 2026-11-14 monthly 0.6 https://www.findatrial.com/study/revive-rusfertide-phase-2 2026-11-14 monthly 0.6 https://www.findatrial.com/study/risankizumab-ulcerative-colitis-trials 2026-11-13 monthly 0.6 https://www.findatrial.com/study/rituximab-cidp-randomized-trial 2026-11-14 monthly 0.6 https://www.findatrial.com/study/rituximab-myasthenia-cochrane 2026-11-13 monthly 0.6 https://www.findatrial.com/study/roam-eortc-1308-radiotherapy-atypical-meningioma 2026-11-14 monthly 0.6 https://www.findatrial.com/study/robust-i-optilume-5-year 2026-11-12 monthly 0.6 https://www.findatrial.com/study/ropeginterferon-pv-meta-analysis 2026-11-14 monthly 0.6 https://www.findatrial.com/study/rosacea-topicals-network-meta-analysis 2026-11-12 monthly 0.6 https://www.findatrial.com/study/rosella-relacorilant-nab-paclitaxel 2026-11-13 monthly 0.6 https://www.findatrial.com/study/rozanolixizumab-cidp-phase-2 2026-11-14 monthly 0.6 https://www.findatrial.com/study/rplnd-seminoma-review 2026-11-12 monthly 0.6 https://www.findatrial.com/study/rtog-0920-cetuximab 2026-11-13 monthly 0.6 https://www.findatrial.com/study/ruby-dostarlimab-4-year-cure-rate 2026-11-13 monthly 0.6 https://www.findatrial.com/study/s1826-adolescents 2026-11-12 monthly 0.6 https://www.findatrial.com/study/s1826-nivolumab-avd 2026-11-12 monthly 0.6 https://www.findatrial.com/study/safusidenib-idh1-glioma-3-year 2026-11-14 monthly 0.6 https://www.findatrial.com/study/sano 2026-11-12 monthly 0.6 https://www.findatrial.com/study/sapablursen-polycythemia-vera-phase-2 2026-11-14 monthly 0.6 https://www.findatrial.com/study/sarc032-pembrolizumab-radiation-surgery 2026-11-14 monthly 0.6 https://www.findatrial.com/study/senscis-nintedanib-limited-cutaneous-ssc 2026-11-14 monthly 0.6 https://www.findatrial.com/study/sentry-selinexor-ruxolitinib 2026-11-14 monthly 0.6 https://www.findatrial.com/study/sequoia-hcm-aficamten 2026-11-14 monthly 0.6 https://www.findatrial.com/study/shape-simple-vs-radical-hysterectomy 2026-11-13 monthly 0.6 https://www.findatrial.com/study/shockwave-cp-cpps-review 2026-11-13 monthly 0.6 https://www.findatrial.com/study/shockwave-peyronies-review 2026-11-12 monthly 0.6 https://www.findatrial.com/study/signal-aa-bempikibart 2026-11-13 monthly 0.6 https://www.findatrial.com/study/simplify-1-momelotinib-anemia-survival 2026-11-14 monthly 0.6 https://www.findatrial.com/study/sjogrens-lymphoma-risk-review 2026-11-13 monthly 0.6 https://www.findatrial.com/study/skyscraper-07 2026-11-12 monthly 0.6 https://www.findatrial.com/study/smart-key-cisplatin-free-larynx-preservation 2026-11-14 monthly 0.6 https://www.findatrial.com/study/smoldering-myeloma-treat-vs-observe-meta-analysis 2026-11-14 monthly 0.6 https://www.findatrial.com/study/sonocloud-carboplatin-recurrent-glioblastoma 2026-11-13 monthly 0.6 https://www.findatrial.com/study/sonrotoclax-mantle-cell-accelerated-approval 2026-11-14 monthly 0.6 https://www.findatrial.com/study/soothe-camlipixant 2026-11-12 monthly 0.6 https://www.findatrial.com/study/soquelitinib-phase-1-final-ptcl 2026-11-14 monthly 0.6 https://www.findatrial.com/study/spearhead-1-afamitresgene-synovial-sarcoma 2026-11-14 monthly 0.6 https://www.findatrial.com/study/ssc-first-transplant 2026-11-12 monthly 0.6 https://www.findatrial.com/study/star-first-pregnancy 2026-11-12 monthly 0.6 https://www.findatrial.com/study/starglo-glofitamab-gemox 2026-11-13 monthly 0.6 https://www.findatrial.com/study/stem-cell-hunner-lesion-trial 2026-11-13 monthly 0.6 https://www.findatrial.com/study/stem-pd 2026-11-12 monthly 0.6 https://www.findatrial.com/study/sunrise-1-tar-200-approval 2026-11-13 monthly 0.6 https://www.findatrial.com/study/surmount-osa 2026-11-12 monthly 0.6 https://www.findatrial.com/study/suzetrigine-sciatica 2026-11-12 monthly 0.6 https://www.findatrial.com/study/swog-s0016-15-year-follicular-cure 2026-11-14 monthly 0.6 https://www.findatrial.com/study/swog-s1702-isatuximab-al-amyloidosis 2026-11-14 monthly 0.6 https://www.findatrial.com/study/sympatico-ibrutinib-venetoclax-relapsed 2026-11-14 monthly 0.6 https://www.findatrial.com/study/synairgy-ad109 2026-11-12 monthly 0.6 https://www.findatrial.com/study/sys6010-first-treatment 2026-11-12 monthly 0.6 https://www.findatrial.com/study/sys6010-vs-chemotherapy 2026-11-12 monthly 0.6 https://www.findatrial.com/study/talquetamab-teclistamab-combination 2026-11-13 monthly 0.6 https://www.findatrial.com/study/tavapadon-tempo-3 2026-11-12 monthly 0.6 https://www.findatrial.com/study/tavns-rosacea-trial 2026-11-12 monthly 0.6 https://www.findatrial.com/study/tebentafusp-5-year-uveal-melanoma 2026-11-13 monthly 0.6 https://www.findatrial.com/study/telitacicept-phase-3-sle 2026-11-13 monthly 0.6 https://www.findatrial.com/study/teprotumumab-long-term-follow-up 2026-11-14 monthly 0.6 https://www.findatrial.com/study/teprotumumab-ted-meta-analysis 2026-11-14 monthly 0.6 https://www.findatrial.com/study/tern-701-mk-4208-phase-1 2026-11-14 monthly 0.6 https://www.findatrial.com/study/testes-trt-safety-evidence-synthesis 2026-11-13 monthly 0.6 https://www.findatrial.com/study/testis-fertility-review 2026-11-12 monthly 0.6 https://www.findatrial.com/study/testis-second-cancers 2026-11-12 monthly 0.6 https://www.findatrial.com/study/testosterone-insulin-resistance-trial 2026-11-13 monthly 0.6 https://www.findatrial.com/study/teton-1-inhaled-treprostinil 2026-11-13 monthly 0.6 https://www.findatrial.com/study/thrive-veligrotug-active-ted 2026-11-14 monthly 0.6 https://www.findatrial.com/study/thymic-postoperative-radiation-review 2026-11-12 monthly 0.6 https://www.findatrial.com/study/tisagenlecleucel-10-year-lymphoma 2026-11-14 monthly 0.6 https://www.findatrial.com/study/tki-advanced-chordoma-review 2026-11-13 monthly 0.6 https://www.findatrial.com/study/tl1a-antibodies 2026-11-12 monthly 0.6 https://www.findatrial.com/study/tocilizumab-ssc-ild-meta-analysis 2026-11-14 monthly 0.6 https://www.findatrial.com/study/tofersen-long-term-sod1-als 2026-11-13 monthly 0.6 https://www.findatrial.com/study/tolebrutinib-fda 2026-11-12 monthly 0.6 https://www.findatrial.com/study/tonmya-resilient 2026-11-12 monthly 0.6 https://www.findatrial.com/study/topaz-1-3-year-durvalumab 2026-11-13 monthly 0.6 https://www.findatrial.com/study/toripalimab-around-surgery 2026-11-12 monthly 0.6 https://www.findatrial.com/study/tovorafenib-pediatric-low-grade-glioma-approval 2026-11-14 monthly 0.6 https://www.findatrial.com/study/tpns-wearable-essential-tremor 2026-11-13 monthly 0.6 https://www.findatrial.com/study/trailblazer-alz-2 2026-11-12 monthly 0.6 https://www.findatrial.com/study/transcend-fl-lisocabtagene-marginal-zone 2026-11-14 monthly 0.6 https://www.findatrial.com/study/triangle-ibrutinib-without-transplant 2026-11-14 monthly 0.6 https://www.findatrial.com/study/trontinemab-early 2026-11-12 monthly 0.6 https://www.findatrial.com/study/ttfields-pembrolizumab-temozolomide-phase-2 2026-11-13 monthly 0.6 https://www.findatrial.com/study/tulisokibart-biomarker-guided-trial 2026-11-13 monthly 0.6 https://www.findatrial.com/study/up-aa-upadacitinib-alopecia 2026-11-13 monthly 0.6 https://www.findatrial.com/study/valentine-ptcl01-valemetostat 2026-11-14 monthly 0.6 https://www.findatrial.com/study/valor-hcm-mavacamten-128-weeks 2026-11-14 monthly 0.6 https://www.findatrial.com/study/vela-sonelokimab-52-week 2026-11-13 monthly 0.6 https://www.findatrial.com/study/verify-rusfertide-approval 2026-11-14 monthly 0.6 https://www.findatrial.com/study/verify-vandetanib 2026-11-12 monthly 0.6 https://www.findatrial.com/study/verona-venetoclax-azacitidine-higher-risk-mds 2026-11-14 monthly 0.6 https://www.findatrial.com/study/viale-a-long-term 2026-11-13 monthly 0.6 https://www.findatrial.com/study/vidofludimus-status 2026-11-12 monthly 0.6 https://www.findatrial.com/study/visionary-sibeprenlimab-interim 2026-11-14 monthly 0.6 https://www.findatrial.com/study/vivacity-mg3-nipocalimab 2026-11-13 monthly 0.6 https://www.findatrial.com/study/vt3989-tead-inhibitor-phase-1-2 2026-11-13 monthly 0.6 https://www.findatrial.com/study/yl201-early 2026-11-12 monthly 0.6 https://www.findatrial.com/study/zenith-sotatercept-high-risk-pah 2026-11-14 monthly 0.6 https://www.findatrial.com/study/zoldonrasib-daraxonrasib-combo-esmo-gi-2026 2026-11-13 monthly 0.6